Head of blood centre vows to keep job despite trial
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.First Edition
THE HEAD of an NHS transfusion centre in Britain said he intends to remain in his post whatever the verdict, due today, of a trial in France where he stands accused of knowingly giving blood products contaminated with the Aids virus to French haemophiliacs, writes Steve Connor.
Jean-Pierre Allain, the director of East Anglian Regional Transfusion Centre, said the trial had been unable to show he did anything wrong during the period between the end of 1984, when scientists had evidence that the factor eight blood-clotting product was contaminated with HIV, and the summer of 1985, when safe, heat-treated versions of the product were issued. During this period he worked for the French blood transfusion service.
'My conscience is absolutely clear, I did all I could at the time to provide haemophiliacs with the best treatment,' he said. If found guilty, he faces a two-year suspended sentence and a fine of 100,000 francs (12,484).
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments